cDNA Arrays: The Ups and Downs Carol A. RemmeM. Paola LombardiRonald H. Lekanne dit Deprez Editorial Introduction Pages: 99 - 101
The Role of ACE-Inhibitors in Patients with Coronary Artery Disease Bertram Pitt Editorial Introduction Pages: 103 - 105
Dopaminergic Agents in Heart Failure: Rebirth of An Old Concept Willem J. Remme Editorial Introduction Pages: 107 - 109
Chronic Catecholamine Depletion Switches Myocardium from Carbohydrate to Lipid Utilisation Angela J. Drake-HollandGer J. Van der VusseMark I.M. Noble OriginalPaper Pages: 111 - 117
The Effects of Streptokinase and Hydroxyethyl Starch on in vitro Clot Disruption by Ultrasound Yehuda AdlerDana AttarYochai Birnbaum OriginalPaper Pages: 119 - 123
cDNA Array Hybridization Reveals Cardiac Gene Expression in Acute Ischemic Murine Hearts Masafumi KitakazeMasanori AsakuraMasatsugu Hori OriginalPaper Pages: 125 - 130
CHF-1024, A DA2/α2 Agonist, Blunts Norepinephrine Excretion and Cardiac Fibrosis in Pressure Overload Serge MassonStefano ChimentiRoberto Latini OriginalPaper Pages: 131 - 138
Autonomic and hemodynamic effects of a new selective dopamine agonist, CHF1035, in patients with chronic heart failure Geert TjeerdsmaLeen M. van WijkDirk J. van Veldhuisen OriginalPaper Pages: 139 - 145
Metabolism of Hepatocyte Growth Factor in the Heart in Patients with Coronary Artery Disease: Implication for Coronary Arteriosclerosis Kouki WatanabeHiroshi FukudaMichihito Sekiya OriginalPaper Pages: 147 - 153
Intravenous Amiodarone Decreases the Duration of Atrial Fibrillation Associated with Acute Myocardial Infarction Dimitrios A. KontoyannisMaria I. Anastasiou-NanaJohn N. Nanas OriginalPaper Pages: 155 - 160
Neurocardiogenic Syncope in Selected Pediatric Patients—Natural History during Long-Term Follow-Up and Effect of Prophylactic Pharmacological Therapy Mauro BiffiGiuseppe BorianiAngelo Branzi OriginalPaper Pages: 161 - 167
The EUROPA Trial: Design, Baseline Demography and Status of the Substudies Abba H. GommaKim M. Fox OriginalPaper Pages: 169 - 179
Should Investigators be Involved in More Than One Similar Type Trial? Christian Torp-PedersenLars Køber OriginalPaper Pages: 181 - 185
Should α1-Antagonists be Avoided as First-Line Antihypertensive Therapy? Sundeep S Salvi Letter to the Editor Pages: 187 - 188
Factors Determining Spontaneous Ventricular Defibrillation Narcis TribulovaMordechai Manoach Letter to the Editor Pages: 189 - 190